α
AlphaScala
StocksSignalsNEWAlpha ScoreBrokers
Sign InGet Started
α
AlphaScala

Professional trading analysis with publicly tracked portfolios on TipRanks. Real trades, real data.

Markets

ForexStocksCryptoCommodities

Tools

Stock ResearchMarket SignalsAlpha ScoreHedge Funds 13FInsider BuysAgentic TradingAI Broker MatcherBroker ReviewsPortfoliosFree IndicatorsBlogLearn TradingTrading Q&A

Account

Sign InDashboardNewsletterContact UsAdvertise

Legal

AboutEditorial PolicyCorrectionsTerms of ServicePrivacy PolicyRisk Disclaimer

Risk Warning: AlphaScala provides educational content only and is not a financial advisor. Trading and investing involves substantial risk of loss and is not suitable for all investors. Past performance does not guarantee future results. You should consult a licensed financial advisor before making investment decisions. See our full risk disclaimer.

For AI AgentsAlphaScala is agent-ready —skill.md·llms.txt
© 2026 ROGA AI LIMITED · Registered in Gibraltar · Unit G02, Eurocity, Europort Avenue, Gibraltar GX11 1AAAlphaScala — Built with data, not hype.
All Stocks/Healthcare/TWST

Twist Bioscience Corp

TWST
HealthcareDiagnostics & Research Website
Signal SnapshotMarket signals →
Alpha Score
Score pending
Alpha Score appears once the required price and fundamentals data has ingested.
Daily model
Insiders
No recent signal
No recent open-market insider buying or selling is in the current rollup.
Form 4
13F Holder
ARK Invest
$239.79M reported position; latest action: new.
Cathie Wood
Latest Filing
No filing digest
Recent 10-K, 10-Q, and 8-K summaries will appear here when available.
SEC digest
Price ChartPowered by TradingView
Ask about TWSTAI research agent
Top Institutional HoldersFrom 13F filings
FundShares HeldPosition ValueAction (latest Q)
ARK Invest
Cathie Wood
7.56M$239.79MNEW
Citadel
Ken Griffin
114K$3.61MNEW
D.E. Shaw
David Shaw
28K$874.9KNEW
Explore all tracked funds →
About Twist Bioscience Corp

Twist Bioscience Corporation is a synthetic biology company that manufactures and sells synthetic DNA-based products through a proprietary semiconductor-based platform. This disruptive technology synthesizes DNA on silicon chips rather than traditional plastic plates, enabling high-quality, high-throughput production that is faster and more cost-effective for large-scale applications. The company offers synthetic genes and gene fragments for therapeutics, diagnostics, chemicals and materials, food and agriculture, data storage, and academic research, serving biotech, pharmaceutical, industrial chemical, agricultural firms, and labs. Additional products include oligo pools for targeted next-generation sequencing (NGS), CRISPR gene editing, mutagenesis, DNA origami, DNA computing, and other advanced uses. Twist Bioscience also provides specialized services such as in vivo antibody discovery with humanized transgenic mouse models and customizable oncology DNA comprehensive genomic profiling (CGP) panels that are platform-agnostic for precision medicine. Recent expansions include express delivery for all gene fragments, collaborations for NGS workflows in agrigenomics, and end-to-end solutions with partners. Headquartered in South San Francisco, California, Twist Bioscience operates across the Americas, EMEA, and APAC regions, playing a pivotal role in accelerating biological engineering and innovation in life sciences.

CEO
Dr. Emily Marine Leproust Ph.D.
Employees
979
Quick Facts
Exchange—
SectorHealthcare
IndustryDiagnostics & Research
Market Cap—
Popular Stocks
AAPL
Apple Inc.
MSFT
Microsoft Corporation
NVDA
NVIDIA Corporation
AMZN
Amazon.com Inc.
GOOGL
Alphabet Inc. Class A
GOOG
Alphabet Inc. Class C
META
Meta Platforms Inc.
TSLA
Tesla Inc.
Key Dates

Earnings calendar coming soon. Subscribe to get notified when TWST reports next.

Get earnings alerts →